Literature DB >> 1446467

Sleep-disordered breathing in patients with Duchenne muscular dystrophy using negative pressure ventilators.

N S Hill1, S Redline, M A Carskadon, F J Curran, R P Millman.   

Abstract

We studied the occurrence of nocturnal disordered breathing events and O2 desaturations in 12 patients with late-stage Duchenne muscular dystrophy (DMD) using negative pressure ventilators. We also assessed the effects of O2 supplementation and nasal continuous positive airway pressure (CPAP) on disordered breathing events in selected patients and examined sleep quality in a small subgroup. Average age was 23 + 2 years and FVC was 293 + 33 ml. Eleven of the 12 patients had more than five disordered breathing events per hour during nocturnal monitoring, and the lowest O2 saturation was < 85 percent in nine patients. Nasal O2 (2 L/min) during negative pressure ventilation in four patients did not alter the frequency of disordered breathing events, prolonged the mean and maximum durations of events, and failed to eliminate severe O2 desaturations in two patients. Nasal CPAP was used in two patients during negative pressure ventilation and completely eliminated disordered breathing events in both. Overnight polysomnography during negative pressure ventilation in three patients demonstrated frequent awakenings that fell in frequency following elective tracheostomy in two patients and use of nasal CPAP in one. We conclude that negative pressure ventilation in patients with late-stage DMD is associated with frequent disordered breathing events and severe O2 desaturations in many patients. Concomitant use of O2 supplementation may prolong the events, but a switch to positive pressure ventilation or addition of nasal CPAP is effective therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446467     DOI: 10.1378/chest.102.6.1656

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline.

Authors:  Douglas A McKim; Jeremy Road; Monica Avendano; Steve Abdool; Fabien Cote; Nigel Duguid; Janet Fraser; Fracois Maltais; Debra L Morrison; Colleen O'Connell; Basil J Petrof; Karen Rimmer; Robert Skomro
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

2.  Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy.

Authors:  A K Simonds; F Muntoni; S Heather; S Fielding
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 3.  Sleep Disordered Breathing in Duchenne Muscular Dystrophy.

Authors:  Antonella LoMauro; Maria Grazia D'Angelo; Andrea Aliverti
Journal:  Curr Neurol Neurosci Rep       Date:  2017-05       Impact factor: 5.081

Review 4.  Breathing in Duchenne muscular dystrophy: translation to therapy.

Authors:  Doreen Z Mhandire; David P Burns; Angela L Roger; Ken D O'Halloran; Mai K ElMallah
Journal:  J Physiol       Date:  2022-06-24       Impact factor: 6.228

Review 5.  Negative-Pressure Ventilation in Neuromuscular Diseases in the Acute Setting.

Authors:  Anna Annunziata; Cecilia Calabrese; Francesca Simioli; Antonietta Coppola; Martina Flora; Antonella Marotta; Valentina Di Spirito; Francesco Didonna; Marcellino Cicalese; Giuseppe Fiorentino
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

Review 6.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

7.  Within-breath control of genioglossal muscle activation in humans: effect of sleep-wake state.

Authors:  Robert B Fogel; John Trinder; Atul Malhotra; Michael Stanchina; Jill K Edwards; Karen E Schory; David P White
Journal:  J Physiol       Date:  2003-06-13       Impact factor: 5.182

8.  Central sleep related breathing disorders - diagnostic and therapeutic features.

Authors:  Heinrich F Becker
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2006-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.